SUNNYVALE, CA--(Marketwired - April 01, 2015) - Viveve Medical, Inc. ("Viveve") (VIVMF), a company focused on women's health, today announced a new distribution partnership with Global DIA Solutions S.L. ("GDS"), a distributor of medical devices based in Barcelona, Spain with offices in Madrid and Valencia. This partnership combines GDS's expertise in building new medical device markets throughout Spain with Viveve's innovative product for treating vaginal laxity. The Viveve® Treatment is now available throughout the United Kingdom, Ireland, and Spain.
"Launching the globally patented Viveve System, which provides a safe, painless treatment for vaginal laxity, in Spain represents a great milestone for Viveve. Vaginal laxity is a medical condition that we believe remains ineffectively addressed for millions of women worldwide. As evidenced by the Spanish enrollment in the VIVEVE I study, the first randomized controlled study for vaginal laxity, the interest in Spain for the Viveve Treatment is significant. Working with GDS to introduce the procedure into Spain will help to ensure that physicians receive the best possible training and support as they begin offering the treatment," said Patricia Scheller, the Chief Executive Officer of Viveve.
Global DIA Solutions offers innovative solutions to healthcare professionals and has a history of offering clinically proven, cutting-edge technologies. The experienced management team focuses on patient satisfaction and providing exemplary clinical support for its customers.
"Global DIA Solutions is proud to add the Viveve System to its portfolio. It aligns perfectly with our mission to provide pioneering technologies to our customers. Now women who have this very common and frustrating condition will have access to a clinically proven procedure that is aimed at reducing vaginal laxity and restoring sexual satisfaction," said Jorge Alorda Guibernau, Sole Administrator of Global DIA Solutions. "We are truly excited to be the exclusive Spanish distributor of the new Viveve System, offering this unique product to physicians and their female patients and contributing to the improvement of women's sexual health."
About Viveve
Viveve, Inc., the operating subsidiary of Viveve Medical, Inc., is a women's health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The company's lead product, the globally patented Viveve® System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue with only one treatment session. The Viveve System treats the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth that can result in a decrease in physical sensation and sexual satisfaction. Physician surveys indicate that vaginal laxity is the number one post-delivery physical change for women, being more prevalent than weight gain, urinary incontinence or stretch marks. The Viveve Treatment uses patented, reverse-thermal gradient radiofrequency technology to tighten vaginal tissue in one 30-minute out-patient treatment in a physician's office. The Viveve System has received regulatory approval in Europe, Canada and Hong Kong and is available through physician import license in Japan. It is currently not available for sale in the U.S. For more information, please visit Viveve's website at www.viveve.com.